Mice Ideas

Changing Paradigm in Management of CML in India - 12 June 2020

Part 1 - Welcome Introduction - Dr Hemant Malhotra, Jaipur

Part 2 - What's new in the 2020 ELN guidelines? - Dr Tulika Seth, Delhi

Part 3 - Essentials of Molecular Monitoring in CML - Dr Pankaj Malhotra, Chandigarh

Part 4 - II Gen TKI as I line in every CML patient in India - Dr K Govind Babu, Bengaluru

Part 5- Patients with newly diagnosed CML-CP in India should receive 2nd Gen TKIs- Dr Dinesh Bhurani

Part 6 - Understanding & Managing TKI toxicities - Dr Col Prakash Chitalkar, Indore

Part 7 - Treatment Free Remission (TFR) in CML : Status Update - Dr Hari Menon, Bengaluru

Part 8 - Panel Discussion: Treating CML in India - Practical Considerations - Dr Hemant Malhotra